What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Dopamine
- Neuroscience
The scientist’s investigation covers issues in Neuroscience, Nucleus accumbens, Hippocampus, Neurotrophic factors and Internal medicine.
Michel Barrot undertakes interdisciplinary study in the fields of Neuroscience and CREB through his research.
His Nucleus accumbens research includes elements of Ventral tegmental area, Epigenetics of cocaine addiction, Addiction and Amygdala.
His Hippocampus research focuses on Hippocampal formation and how it relates to Neurogenesis and Morphine.
His Internal medicine study frequently draws connections between adjacent fields such as Endocrinology.
Michel Barrot focuses mostly in the field of Melanin-concentrating hormone, narrowing it down to matters related to Orexin receptor and, in some cases, Pharmacology.
His most cited work include:
- Neurobiology of depression. (2491 citations)
- Essential role of brain-derived neurotrophic factor in adult hippocampal function (540 citations)
- Opiates inhibit neurogenesis in the adult rat hippocampus. (528 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Neuroscience, Neuropathic pain, Pharmacology, Ventral tegmental area and Nucleus accumbens.
His Neuroscience research focuses on Nociception and how it connects with Neurotrophin.
His study in Neuropathic pain is interdisciplinary in nature, drawing from both Antidepressant, Nortriptyline, Chronic pain and Allodynia.
The study incorporates disciplines such as Endogeny and Opioid in addition to Pharmacology.
His Ventral tegmental area study which covers Inhibitory postsynaptic potential that intersects with Neurotransmission.
Michel Barrot has researched Nucleus accumbens in several fields, including AMPA receptor and Striatum.
He most often published in these fields:
- Neuroscience (59.84%)
- Neuropathic pain (34.65%)
- Pharmacology (34.65%)
What were the highlights of his more recent work (between 2015-2021)?
- Neuropathic pain (34.65%)
- Pharmacology (34.65%)
- Opioid (16.54%)
In recent papers he was focusing on the following fields of study:
Neuropathic pain, Pharmacology, Opioid, Chronic pain and Neuroscience are his primary areas of study.
His Neuropathic pain research incorporates elements of Antidepressant, Lesion, Pregabalin and Allodynia.
His study in Neuroscience focuses on Ventral tegmental area, Sensory system, Anterior cingulate cortex, Excitatory postsynaptic potential and Inhibitory postsynaptic potential.
Michel Barrot studies Rostromedial tegmental nucleus which is a part of Ventral tegmental area.
His Anterior cingulate cortex research incorporates themes from Hippocampus and Prefrontal cortex.
His studies deal with areas such as Nucleus accumbens, Striatum and Calorie as well as Midbrain.
Between 2015 and 2021, his most popular works were:
- Antidepressants and gabapentinoids in neuropathic pain: Mechanistic insights. (120 citations)
- Hyperactivity of Anterior Cingulate Cortex Areas 24a/24b Drives Chronic Pain-Induced Anxiodepressive-like Consequences. (58 citations)
- Afferents to anterior cingulate areas 24a and 24b and midcingulate areas 24a′ and 24b′ in the mouse (37 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Dopamine
- Neurotransmitter
Michel Barrot focuses on Opioid, Neuropathic pain, Neuroscience, Duloxetine and Pharmacology.
He combines subjects such as Substantia nigra, Ventral tegmental area, Stimulation and Aversive Stimulus with his study of Opioid.
His Neuroscience research focuses on Sensory system, Anterior cingulate cortex, Rostromedial tegmental nucleus, Basal forebrain and Dopamine.
His Anterior cingulate cortex study combines topics in areas such as Diagonal band of Broca, Thalamus, Brainstem, Prefrontal cortex and Hippocampus.
His research integrates issues of Antidepressant, Amitriptyline, Pregabalin and Nervous system in his study of Duloxetine.
His Pharmacology research is multidisciplinary, incorporating elements of Tricyclic antidepressant and Allodynia.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
